Welcome to the official website of BioCoreUSA Corp!
EN
              home > TISSUE ARRAYS > Ovary > FOV1502
              • Cores:
                150
                CASES:
                75
                Core Diameter(mm):
                1
                Thickness(µm):
                5
                Row number:
                10
                Column number:
                15
                Tissue Array Type:
                FFPE
                Species:
                Human
              FOV1502
              $215.00
              Add To Collect

              Description: Ovary adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores

              Details: Ovarian adenocarcinoma tissue microarray, containing 37 cases of serous adenocarcinoma, 18 mucinous adenocarcinoma, 5 endometrioid adenocarcinoma, 3 clear cell carinoma, 3 endodermal sinus cancer, 3 granular cell tumor, 1 neuroendocrine carcinoma, plus 5 adjacent normal ovary tissue, duplicate cores per case

              Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

              Please Select Tissue Array Type:
              Tag:
              150 Cores75 CasesOvary duplicate cores per case Matched or Unmatched special price
              Add To Cart
              Outright purchase
              Note

              1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
              2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
              In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

              • Specification sheet
              • Overlapping case
              • Download specifications
              Legend:
              Car-Cardia Eso-Fsophagus
              • Malignant(I)
              • Malignant(IA)
              • Malignant(IB)
              • Malignant(IC)
              • Malignant(IIB)
              • Malignant(II)
              • Malignant(IIIA)
              • Malignant(IIIC)
              • Malignant(III)
              • NAT(-)
              • _ma
              TISSUE ARRAYS
              FOV1502
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10
              11
              12
              13
              14
              15
              A
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              B
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              C
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              D
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              E
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              F
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              G
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              H
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              I
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              J
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              Ova
              _ma
              FOV1502
              • Age:
              • Sex:
              • Organ/Anatomic Site:
              • Pathology diagnosis:
              • Grade:
              • TNM:
              • Stage:
              • Tissue ID.:
              • Type:
              Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size Ki-67 CK
              A1
              		 1 29 F Ovary Serous adenocarcinoma 1 T1N0M0 I Malignant - +,15% ++,100%
              A2
              		 2 40 F Ovary Serous adenocarcinoma 1 T1aN0M0 IA Malignant - +,5% +++,100%
              A3
              		 3 41 F Ovary Serous adenocarcinoma 1 T1N0M0 I Malignant 6*4*2.5 +,5% ++,100%
              A4
              		 4 23 F Ovary Serous adenocarcinoma 1 T2bN0M0 IIB Malignant 2.8*2*1.5 +,5% ++,100%
              A5
              		 5 45 F Ovary Serous adenocarcinoma 1 T1aN0M0 IA Malignant - +,5% ++,100%
              A6
              		 6 35 F Ovary Serous papillary adenocarcinoma (interstitial) * T1cN0M0 IC Malignant 15*10*4 - ++,100%，少量癌细胞
              A7
              		 7 75 F Ovary Serous papillary adenocarcinoma 2 T1aN0M0 IA Malignant - +,5% +,80%
              A8
              		 8 49 F Ovary Serous adenocarcinoma 2 T1N0M0 I Malignant 8*4.5*4 +,15% +,80%
              A9
              		 9 53 F Ovary Serous adenocarcinoma 2 T3N0M0 III Malignant 4*3*1.5 +,10% +,80%
              A10
              		 10 39 F Ovary Serous adenocarcinoma 2--3 T3cN0M0 IIIC Malignant 6*4*4 +,10% ++,90%
              A11
              		 11 49 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 6*5.5*5 +,15% ++,80%
              A12
              		 12 79 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant 14*8*6 +,5% ++,60%
              A13
              		 13 56 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 6*5*3 +,5% +,30%
              A14
              		 14 57 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 9*5*4 +,5% ++,70%
              A15
              		 15 58 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 9*5.5*2 +,10% +,30%
              B1
              		 16 29 F Ovary Serous adenocarcinoma 1 T1N0M0 I Malignant - +,15% ++,100%
              B2
              		 17 40 F Ovary Serous adenocarcinoma 1 T1aN0M0 IA Malignant - +,5% ++,100%
              B3
              		 18 41 F Ovary Serous adenocarcinoma 1 T1N0M0 I Malignant 6*4*2.5 - ++,100%
              B4
              		 19 23 F Ovary Serous adenocarcinoma 1 T2bN0M0 IIB Malignant 2.8*2*1.5 +,5% ++,90%
              B5
              		 20 45 F Ovary Serous adenocarcinoma 1 T1aN0M0 IA Malignant - +,5% ++,100%
              B6
              		 21 35 F Ovary Serous papillary adenocarcinoma 2 T1cN0M0 IC Malignant 15*10*4 +,5% ++,100%
              B7
              		 22 75 F Ovary Serous papillary adenocarcinoma 2 T1aN0M0 IA Malignant - +,10% +,90%
              B8
              		 23 49 F Ovary Serous adenocarcinoma 2 T1N0M0 I Malignant 8*4.5*4 +,15% ++,80%
              B9
              		 24 53 F Ovary Serous adenocarcinoma 2 T3N0M0 III Malignant 4*3*1.5 +,10% ++,80%
              B10
              		 25 39 F Ovary Serous adenocarcinoma 2--3 T3cN0M0 IIIC Malignant 6*4*4 +,5% ++,70%
              B11
              		 26 49 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 6*5.5*5 +,15% ++,90%
              B12
              		 27 79 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant 14*8*6 +,5% ++,80%
              B13
              		 28 56 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 6*5*3 +,5% +,50%
              B14
              		 29 57 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 9*5*4 +,5% ++,90%
              B15
              		 30 58 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 9*5.5*2 +,5% ++,60%
              C1
              		 31 51 F Ovary Serous adenocarcinoma 3 T1bN0M0 IB Malignant 8*6*2 +,5%，掉片 +,60%，掉片
              C2
              		 32 75 F Ovary Serous adenocarcinoma with sparse necrosis 3 T1N0M0 I Malignant 5*4*3 +,15% ++,100%
              C3
              		 33 51 F Ovary Serous adenocarcinoma with sparse necrosis 3 T1aN0M0 IA Malignant 7*6*4 - ++,100%
              C4
              		 34 43 F Ovary Serous adenocarcinoma 3 T3N0M0 III Malignant - - ++,80%
              C5
              		 35 53 F Ovary Serous adenocarcinoma 2 T3N1M0 IIIC Malignant 3*2*1 +,20% ++,90%
              C6
              		 36 55 F Ovary Serous adenocarcinoma 2--3 T1aN0M0 IA Malignant 4.5*3.0*3.0 +,5% ++,70%
              C7
              		 37 41 F Ovary Serous adenocarcinoma with sparse necrosis 3 T3N0M0 III Malignant - +,20% +,70%
              C8
              		 38 55 F Ovary Serous adenocarcinoma 3 T1cN0M0 IC Malignant 9 - ++,100%
              C9
              		 39 67 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant 9*6*5.5 - +,60%
              C10
              		 40 48 F Ovary Serous adenocarcinoma 3 T3aN0M0 IIIA Malignant 7*4*2.5 +,15% ++,90%
              C11
              		 41 67 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 13*12*6 +,15% ++,70%
              C12
              		 42 43 F Ovary Serous adenocarcinoma 3 T3cN0M0 IIIC Malignant 8*7*4 +,10% ++,90%
              C13
              		 43 37 F Ovary Serous adenocarcinoma 2 T1aN0M0 IA Malignant 6.5*4.5*3.0 ++,40% ++,90%
              C14
              		 44 49 F Ovary Serous adenocarcinoma 3 T3N1M0 IIIC Malignant 9 +,10% ++,90%
              C15
              		 45 58 F Ovary Serous adenocarcinoma 3 T3cN0M0 IIIC Malignant - +,15% ++,90%
              D1
              		 46 51 F Ovary Serous adenocarcinoma 3 T1bN0M0 IB Malignant 8*6*2 +,5% ++,80%
              D2
              		 47 75 F Ovary Serous adenocarcinoma (sparse) 3 T1N0M0 I Malignant 5*4*3 +,10% ++,90%
              D3
              		 48 51 F Ovary Serous adenocarcinoma with sparse necrosis 3 T1aN0M0 IA Malignant 7*6*4 +,5% ++,50%
              D4
              		 49 43 F Ovary Serous adenocarcinoma 2--3 T3N0M0 III Malignant - - +,60%
              D5
              		 50 53 F Ovary Serous adenocarcinoma with nerosis (sparse) 2 T3N1M0 IIIC Malignant 3*2*1 +,10% ++,60%
              D6
              		 51 55 F Ovary Serous adenocarcinoma 2 T1aN0M0 IA Malignant 4.5*3.0*3.0 +,5% ++,90%
              D7
              		 52 41 F Ovary Serous adenocarcinoma with sparse necrosis 3 T3N0M0 III Malignant - ++,25% +,90%
              D8
              		 53 55 F Ovary Serous adenocarcinoma 3 T1cN0M0 IC Malignant 9 - ++,100%
              D9
              		 54 67 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant 9*6*5.5 +,5% ++,60%
              D10
              		 55 48 F Ovary Serous adenocarcinoma with sparse necrosis 3 T3aN0M0 IIIA Malignant 7*4*2.5 +,15% ++,80%
              D11
              		 56 67 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 13*12*6 +,15% ++,70%
              D12
              		 57 43 F Ovary Serous adenocarcinoma (sparse) 3 T3cN0M0 IIIC Malignant 8*7*4 +,5% ++,100%
              D13
              		 58 37 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant 6.5*4.5*3.0 ++,25% ++,100%
              D14
              		 59 49 F Ovary Serous adenocarcinoma with sparse necrosis 3 T3N1M0 IIIC Malignant 9 +,10% ++,90%
              D15
              		 60 58 F Ovary Serous adenocarcinoma 3 T3cN0M0 IIIC Malignant - - ++,90%
              E1
              		 61 43 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant - - ++,90%
              E2
              		 62 56 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant - +,5% ++,100%
              E3
              		 63 52 F Ovary Serous adenocarcinoma 2 T3N0M0 III Malignant - +,5% ++,90%
              E4
              		 64 50 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant - +,5% ++,90%
              E5
              		 65 40 F Ovary Serous adenocarcinoma (interstitial) * T1aN0M0 IA Malignant - +,5% +,70%，癌少
              E6
              		 66 47 F Ovary Serous adenocarcinoma 3 T1aN1M0 IIIC Malignant 7 +,5% +,70%
              E7
              		 67 46 F Ovary Serous adenocarcinoma 3 T2bN1M0 IIIC Malignant 6 +,10% ++,60%
              E8
              		 68 69 F Ovary Mucinous adenocarcinoma 1 T1bN0M0 IB Malignant - - +,60%
              E9
              		 69 34 F Ovary Mucinous adenocarcinoma 1 T1bN0M0 IB Malignant - +,15% ++,80%
              E10
              		 70 54 F Ovary Mucinous adenocarcinoma 1 T1bN0M0 IB Malignant - +,10% ++,80%
              E11
              		 71 49 F Ovary Mucinous adenocarcinoma 1 T1N0M0 I Malignant 8.5*6*2 +,5% ++,100%
              E12
              		 72 35 F Ovary Mucinous adenocarcinoma 2 T1bN0M0 IB Malignant - +,15% ++,100%
              E13
              		 73 57 F Ovary Mucinous adenocarcinoma 2 T1bN0M0 IB Malignant 10*10 - +,30%
              E14
              		 74 48 F Ovary Mucinous adenocarcinoma 2 T1aN0M0 IA Malignant - +,10% ++,100%
              E15
              		 75 35 F Ovary Mucinous adenocarcinoma (necrosis) * T3aN1M0 IIIC Malignant 24*16*9 - +,10%，癌很少
              F1
              		 76 43 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant - - ++,100%
              F2
              		 77 56 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant - +,5% ++,100%
              F3
              		 78 52 F Ovary Serous adenocarcinoma 2 T3N0M0 III Malignant - +,10% ++,90%
              F4
              		 79 50 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant - +,10% ++,90%
              F5
              		 80 40 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant - +,10% ++,90%
              F6
              		 81 47 F Ovary Serous adenocarcinoma with sparse necrosis 3 T1aN1M0 IIIC Malignant 7 - +,80%
              F7
              		 82 46 F Ovary Serous adenocarcinoma 3 T2bN1M0 IIIC Malignant 6 +,10% ++,80%
              F8
              		 83 69 F Ovary Mucinous adenocarcinoma 1 T1bN0M0 IB Malignant - - ++,70%
              F9
              		 84 34 F Ovary Mucinous adenocarcinoma 1 T1bN0M0 IB Malignant - +,15% ++,70%
              F10
              		 85 54 F Ovary Mucinous adenocarcinoma (sparse) 1 T1bN0M0 IB Malignant - +,5% ++,100%
              F11
              		 86 49 F Ovary Mucinous adenocarcinoma 1 T1N0M0 I Malignant 8.5*6*2 +,10% ++,90%
              F12
              		 87 35 F Ovary Mucinous adenocarcinoma 2 T1bN0M0 IB Malignant - +,15% ++,90%
              F13
              		 88 57 F Ovary Mucinous adenocarcinoma with sparse necrosis 2 T1bN0M0 IB Malignant 10*10 - +,40%
              F14
              		 89 48 F Ovary Mucinous adenocarcinoma 2 T1aN0M0 IA Malignant - +,15% ++,90%
              F15
              		 90 35 F Ovary Mucinous adenocarcinoma with necrosis 2 T3aN1M0 IIIC Malignant 24*16*9 +,15% +,80%
              G1
              		 91 41 F Ovary Mucinous adenocarcinoma with necrosis (sparse) 2 T1aN0M0 IA Malignant - +,5%，癌很少 +++,100%，癌很少，坏死多
              G2
              		 92 40 F Ovary Mucinous adenocarcinoma 2 T1cN0M0 IC Malignant - +,10% ++,90%
              G3
              		 93 67 F Ovary Mucinous adenocarcinoma 2 T1N0M0 I Malignant - +,15% ++,80%
              G4
              		 94 47 F Ovary Mucinous adenocarcinoma 2 T1aN0M0 IA Malignant 7*5*4 +,5% ++,80%
              G5
              		 95 49 F Ovary Mucinous adenocarcinoma 2 T1aN0M0 IA Malignant 5*4*3.5 +,10% ++,70%
              G6
              		 96 52 F Ovary Mucinous adenocarcinoma 2 T1aN0M0 IA Malignant - ++，40% ++,50%
              G7
              		 97 54 F Ovary Mucinous adenocarcinoma 3 T1N0M0 I Malignant 11*6*5 +,20% ++,50%
              G8
              		 98 61 F Ovary Mucinous adenocarcinoma 3 T1cN0M0 IC Malignant - - +,80%
              G9
              		 99 50 F Ovary Mucinous adenocarcinoma 3 T2N0M0 II Malignant 7*4*4 +,10% +,80%
              G10
              		 100 45 F Ovary Mucinous adenocarcinoma 3 T1aN0M0 IA Malignant - +,5% ++,90%
              G11
              		 101 55 F Ovary Endometrioid adenocarcinoma 1--2 T1aN0M0 IA Malignant 11*9*7 - ++,80%
              G12
              		 102 44 F Ovary Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant - +,5% ++,90%
              G13
              		 103 60 F Ovary Endometrioid adenocarcinoma 2 T3N0M0 III Malignant - +,5% ++,90%
              G14
              		 104 49 F Ovary Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant 12*11*5 - ++,50%
              G15
              		 105 54 F Ovary Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 4.5*2.5*2 - +,80%
              H1
              		 106 41 F Ovary Mucinous adenocarcinoma (necrosis) * T1aN0M0 IA Malignant - +,5%，癌很少 +++,100%，癌很少，坏死多
              H2
              		 107 40 F Ovary Mucinous adenocarcinoma 2 T1cN0M0 IC Malignant - +,10% ++,90%
              H3
              		 108 67 F Ovary Mucinous adenocarcinoma 2 T1N0M0 I Malignant - +,15% ++,80%
              H4
              		 109 47 F Ovary Mucinous adenocarcinoma 2 T1aN0M0 IA Malignant 7*5*4 +,5% ++,80%
              H5
              		 110 49 F Ovary Mucinous adenocarcinoma 2 T1aN0M0 IA Malignant 5*4*3.5 +,10% ++,70%
              H6
              		 111 52 F Ovary Mucinous adenocarcinoma 2 T1aN0M0 IA Malignant - ++，40% ++,80%
              H7
              		 112 54 F Ovary Mucinous adenocarcinoma 3 T1N0M0 I Malignant 11*6*5 +,20% ++,60%
              H8
              		 113 61 F Ovary Mucinous adenocarcinoma 3 T1cN0M0 IC Malignant - - +,80%
              H9
              		 114 50 F Ovary Mucinous adenocarcinoma 2--3 T2N0M0 II Malignant 7*4*4 +,10% +,80%
              H10
              		 115 45 F Ovary Mucinous adenocarcinoma 3 T1aN0M0 IA Malignant - +,5% ++,90%
              H11
              		 116 55 F Ovary Endometrioid adenocarcinoma 1--2 T1aN0M0 IA Malignant 11*9*7 - ++,90%
              H12
              		 117 44 F Ovary Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant - +,5% ++,90%
              H13
              		 118 60 F Ovary Endometrioid adenocarcinoma 2 T3N0M0 III Malignant - +,5% ++,90%
              H14
              		 119 49 F Ovary Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant 12*11*5 - ++,90%
              H15
              		 120 54 F Ovary Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 4.5*2.5*2 - +,80%
              I1
              		 121 61 F Ovary Clear cell carcinoma 2 T1aN0M0 IA Malignant 12*6*6 +,10% +,60%
              I2
              		 122 42 F Ovary Clear cell carcinoma 2 T1aN0M0 IA Malignant 9.5*5*1 +,5% +,30%
              I3
              		 123 43 F Ovary Clear cell carcinoma 2 T1aN0M0 IA Malignant 7*4*3 - ++,80%
              I4
              		 124 12 F Ovary Endodermal sinus tumor - T1bN0M0 IB Malignant 13*8*8 - +,80%
              I5
              		 125 14 F Ovary Endodermal sinus tumor - T1cN0M0 IC Malignant 15*13*10 - +,60%
              I6
              		 126 19 F Ovary Endodermal sinus tumor - T1aN0M0 IA Malignant 11*10*9 +，10% +,60%
              I7
              		 127 84 F Ovary Granular cell tumor - T1aN0M0 IA Malignant 10*6*0.8 - -
              I8
              		 128 10 F Ovary Juvenile granulosa cell tumor - T1aN0M0 IA Malignant 12*9*6 +,5% +,80%
              I9
              		 129 49 F Ovary Granular cell tumor - T1N0M0 I Malignant 8*7*6 +,5% -
              I10
              		 130 45 F Ovary Neuroendocrine carcinoma with necrosis - T1aN0M0 IA Malignant 5.0*4.5*3.0 ++，40% -
              I11
              		 131 48 F Ovary Adjacent normal ovary tissue - - - NAT - - -
              I12
              		 132 29 F Ovary Adjacent normal ovary tissue - - - NAT - - -
              I13
              		 133 51 F Ovary Adjacent normal ovary tissue - - - NAT - - -
              I14
              		 134 52 F Ovary Adjacent normal ovary tissue - - - NAT - 掉片 掉片
              I15
              		 135 41 F Ovary Adjacent normal ovary tissue - - - NAT - - -
              J1
              		 136 61 F Ovary Clear cell carcinoma 2 T1aN0M0 IA Malignant 12*6*6 +,10% +,60%
              J2
              		 137 42 F Ovary Clear cell carcinoma 2 T1aN0M0 IA Malignant 9.5*5*1 +,5% +,30%
              J3
              		 138 43 F Ovary Clear cell carcinoma 2 T1aN0M0 IA Malignant 7*4*3 - +,80%
              J4
              		 139 12 F Ovary Endodermal sinus cancer - T1bN0M0 IB Malignant 13*8*8 +,5% +,80%
              J5
              		 140 14 F Ovary Endodermal sinus cancer - T1cN0M0 IC Malignant 15*13*10 - +,60%
              J6
              		 141 19 F Ovary Endodermal sinus cancer - T1aN0M0 IA Malignant 11*10*9 +，10% +,60%
              J7
              		 142 84 F Ovary Granular cell tumor - T1aN0M0 IA Malignant 10*6*0.8 +,5% -
              J8
              		 143 10 F Ovary Juvenile granulosa cell tumor - T1aN0M0 IA Malignant 12*9*6 +,10% +,60%
              J9
              		 144 49 F Ovary Granular cell tumor - T1N0M0 I Malignant 8*7*6 +,5% -
              J10
              		 145 45 F Ovary Neuroendocrine carcinoma - T1aN0M0 IA Malignant 5.0*4.5*3.0 ++，40% -
              J11
              		 146 48 F Ovary Adjacent normal ovary tissue - - - NAT - - -
              J12
              		 147 29 F Ovary Adjacent normal ovary tissue - - - NAT - - -
              J13
              		 148 51 F Ovary Adjacent normal ovary tissue - - - NAT - - -
              J14
              		 149 52 F Ovary Adjacent normal ovary tissue - - - NAT - 掉片 掉片
              J15
              		 150 41 F Ovary Adjacent normal ovary tissue - - - NAT - - -
              _marker_
              Find overlapping cases with this tissue array:
              • FOV1502
                File Format: .xls
                Release Date: 2025-01-17 16:00:38
                Download
              ArraysBank has pioneering biotechnology in healthcare
              Contact us
              +8888996266

              Technical Support: Info@biocoreusa.com

              Customer Service: Customerservices@biocoreusa.co

              Subscribe to our newsletter andstay up to date with our latest
              Follow us
              Copyright @BioCoreUSA Co,.Ltd.All Rights Reserved.
              1.202870s